All Media

Home
About
Services
Products
R&D
Quality
Investors
Media
Careers

Home
About
Services
Products
R&D
Quality
Investors
Media

All Media

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

Firalis a inauguré la ligne de production automatisée, dédiée au production de "EasyCOV", le test rapide salivaire de dépistage du Covid-19 !

09.12.2020

HAS valide le remboursement d'EasyCOV*

*La Haute Autorité de Santé (HAS) valide l’utilisation et recommande le remboursement du test salivaire EasyCOV® sous conditions.

28.11.2020

TACKLING COVID-19: THE "COVIRNA" PROJECT

A diagnostic test funded by the EU, to improve surveillance and care of COVID-19 patients

27.11.2020

Olink in Covid-19 R&D

Outstanding Olink technology offering for COVID-19 Research

06.08.2020

EasyCov: Covid-19 saliva test

Firalis-produced and CE-marked "EasyCOV" saliva test, developed by Skillcell

18.06.2020

Firalis and EasyCOV on DNA

Firalis and the EasyCOV test are mentioned on an article published by the "DNA" (Les Dernières Nouvelles d'Alsace).

10.05.2020

Firalis on "Point Eco Alsace"

Biomarkers for Future's Medicines

13.03.2020

EU-funded (Eurostars) HeartLinc Program

13.03.2020

Fundraising by Amoneta Diagnostics

13.03.2020

USD 2 million by the Alzheimer’s Drug Discovery Foundation ...

13.03.2020

Champions de la croissance 2020

Firalis is placed as the 229th fastest growing French business in 2020, among 10k participants, as a result of a selection by the partnership of "Les Echos" and "Statista".

13.03.2020

Follow us on

Contact Firalis

Firalis Group

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE

follow Firalis on
Linkedin

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

No more painful NP Swabs
No need for a Laboratory
Since 22/01/2021 officially equal to an RT-PCR Test!
Sample to Result time only 40 Minutes!
Result in an instant thanks to RT-LAMP Technology

LEARN MORE &

GET YOUR QUOTATION NOW !

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

No more painful NP Swabs
No need for a Laboratory
Since 22/01/2021 officially equal to an RT-PCR Test!
Sample to Result time only 40 Minutes!
Result in an instant thanks to RT-LAMP Technology

LEARN MORE &

GET YOUR QUOTATION NOW !

All Media

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

HAS valide le remboursement d'EasyCOV*

TACKLING COVID-19: THE "COVIRNA" PROJECT

Olink in Covid-19 R&D

EasyCov: Covid-19 saliva test

Firalis and EasyCOV on DNA

Firalis against Covid-19 !

Firalis on "Point Eco Alsace"

Theranostic Tool

Firalis on « Les Echos »

EU-funded (Eurostars) HeartLinc Program

Launch of the Biopred panel

Launch of the FiMICS® panel

Fundraising by Amoneta Diagnostics

USD 2 million by the Alzheimer’s Drug Discovery Foundation ...

Champions de la croissance 2020

Firalis Group

follow Firalis on
Linkedin